The extent of injection site infection in injecting drug users: findings from a national surveillance study.

Article English OPEN
Hope, VD ; Marongiu, A ; Parry, JV ; Ncube, F (2010)

Injection site infections in injecting drug users (IDUs) are associated with serious morbidity and healthcare costs. Factors associated with symptoms of these were examined through annual (2006-2008) unlinked-anonymous survey of IDUs in England, Wales and Northern Ireland. Overall 36% (1863/5209) self-reported having a symptom with no trend over time (35% 2006, 37% 2007, 34% 2008). Symptoms were less common in the North East of England; increased with years injecting; and were higher in women, those recently homeless, those recently using a needle exchange, and those injecting both opiates and stimulants. Of those injecting during the previous 4 weeks (n=3733) symptoms were associated with: injecting daily; injecting >or=10 times a day; injecting into hands, groin, or legs; sharing filters; and reusing water to flush syringes. Symptoms of injection site infections are common in IDUs. Better-targeted preventive interventions are needed, and continued surveillance should assist with assessing the impact of new initiatives.
  • References (40)
    40 references, page 1 of 4

    1. Cherubin C, Sapira J. The medical complications of drug addiction and the medical assessment of the intravenous drug user. Annals of Internal Medicine 1993 ; 119 : 1017-1028.

    2. Del Guidice P. Cutaneous complication of intravenous drug abuse. British Journal of Dermatology 2004 ; 150 : 1-10.

    3. Lloyd-Smith E, et al. Risk factors for developing a cutaneous injection-related infection among injection drug users : a cohort study. BMC Public Health 2008 ; 8 : 405.

    4. Salmon AM, et al. Injecting-related injury and disease among clients of a supervised injecting facility. Drug & Alcohol Dependence 2009 ; 101 : 132-136.

    5. Takahasi T, et al. Type and location of injection drug use-related soft tissue infections predict hospitalization. Journal of Urban Health 2003 ; 80 : 127-136.

    6. Biswanger I, et al. High prevalence of abscesses and cellulitis among community-recruited injection drug users in San Fransisco. Clinical Infectious Diseases 2000 ; 30 : 579-581.

    7. Lloyd-Smith E, et al. Prevalence and correlates of abscesses among a cohort of injection drug users. Harm Reduction Journal 2005 ; 2 : 24.

    8. Hope V, et al. Frequency, factors and costs associated with injection site infections : findings from a national multi-site survey of injecting drug users in England. BMC Infectious Diseases 2008 ; 8 : 120.

    9. Kerr T, et al. High rates of primary care and emergency department use among injection drug users in Vancouver. Journal of Public Health (Oxford) 2005 ; 27 : 62-66.

    10. Palepu A, et al. Hospital utilization and costs in a cohort of injection drug users. Canadian Medical Association Journal 2001 ; 165 : 415-420.

  • Metrics
    No metrics available
Share - Bookmark